Immunoreactive Myelin Basic Protein in Tumor Cells Associated with Carcinomatous Neuropathy
Authors:
Open Access
- 1 December 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 84 (6) , 741-743
Abstract
Tumors from two patients with carcinomatous neuropathy were studied with an immunohistochemical method using anti-myelin basic protein (anti-MBP) sera. In both cases, immunoreactive MBP was clearly demonstrated in some of the tumor cells, which were widely distributed either singly or, more often, in clusters. The staining intensity varied from cell to cell. An autoimmune mechanism to nervous elements has been suggested in the pathogenesis of carcinomatous neuropathy. MBP is known to be a highly specific and potent antigen that can induce allergic neuritis in animals. In one patient the progressively worsening neurologic condition rapidly improved after gastrectomy removed the carcinoma. It is possible that immunoreactive MBP in tumor cells may function as an “antigen” in the development of carcinomatous neuropathy.Keywords
This publication has 6 references indexed in Scilit:
- Faulty development of cortical neurons in the snell dwarf cerebrumDevelopmental Brain Research, 1983
- Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lungCancer, 1982
- Immunological cross-reactivity between acid extracts of myelin, liver and neoplastic tissues: studies in immunized guinea-pigsBritish Journal of Cancer, 1979
- Experimental Allergic Neuritis in the Lewis RatJournal of Neuropathology & Experimental Neurology, 1979
- Brain-derived fibroblast growth factor: identity with a fragment of the basic protein of myelin.Proceedings of the National Academy of Sciences, 1978
- ALLERGIC NEURITIS: AN EXPERIMENTAL DISEASE OF RABBITS INDUCED BY THE INJECTION OF PERIPHERAL NERVOUS TISSUE AND ADJUVANTSJournal of Experimental Medicine, 1955